Literature DB >> 8983862

Role of nitric oxide in immune-mediated diseases.

H T Cook, V Cattell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8983862     DOI： 10.1042/cs0910375

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN： 0143-5221            Impact factor:   6.124


× No keyword cloud information.
  6 in total

1.  Cyclic guanosine-3',5'-monophosphate and biopteridine biosynthesis in Nocardia sp.

Authors:  J K Son; J P Rosazza
Journal:  J Bacteriol       Date:  2000-07       Impact factor: 3.490

2.  Induced nitric oxide (NO) synthesis in heterologous nephrotoxic nephritis; effects of selective inhibition in neutrophil-dependent glomerulonephritis.

Authors:  S N Waddington; K Mosley; V Cattell
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

3.  Role of nitric oxide in the impairment of circular muscle contractility of distended, uninflamed mid-colon in TNBS-induced acute distal colitis in rats.

Authors:  Luciano Onori; Annalisa Aggio; Simona D'Alo'; Paola Muzi; Maria Grazia Cifone; Gabriella Mellillo; Rachele Ciccocioppo; Gennaro Taddei; Giuseppe Frieri; Giovanni Latella
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

4.  Nitric oxide and inducible nitric oxide synthase levels in EE and NERD patients.

Authors:  Fatemeh Nejat PishKenari; Durdi Qujeq; Seyed Saeid Mohammady Bonahi; Mehrdad Kashifard; Karimollah Hajian-Tilaki
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2022

5.  Effect of L-NAME, an inhibitor of nitric oxide synthesis, on plasma levels of IL-6, IL-8, TNF alpha and nitrite/nitrate in human septic shock.

Authors:  J A Avontuur; T C Stam; M Jongen-Lavrencic; J G van Amsterdam; A M Eggermont; H A Bruining
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

6.  Nitric oxide levels and the severity of juvenile idiopathic arthritis.

Authors:  Blanca Elena R G Bica; Niele M Gomes; Patrícia D Fernandes; Ronir R Luiz; Vera Lúcia G Koatz
Journal:  Rheumatol Int       Date:  2007-02-08       Impact factor: 3.580
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.